Sequential Screening for Better Hits, Faster
The Beacon platform by Bruker Cellular Analysis is a disruptive, best-in-industry technology for single B cell screening. It enables high-resolution screening of antibody-secreting B cells with throughput and timeline previously unimaginable for antibody discovery.
Our scientists at Twist Biopharma Solutions are the first to adopt this state-of-the-art technology, meaning every obstacle or challenge has been tested and optimized to provide you with all the benefits this platform offers. Days after tissue collection, the Beacon provides a rich data set about each antibody screened to identify the rare and cross-reactive antibodies ideal for clinical development. Those antibodies are sequenced and rapidly expressed in-house to advance them to characterization and developability assays.
In vivo 抗体開発を数ヶ月ではなく数週間で行います
当社なら可能です。The Beacon-based B cell screening enables high-resolution screening for ideal, rare antibodies in previously impossible timelines.
Why is the Beacon Better?
The Beacon offers peak flexibility and resolution, evolved across 3 generations of single B cell screening technologies.
Sequential Screening for Better Hits, Faster
The Beacon platform by Bruker Cellular Analysis is a disruptive, best-in-industry technology for single B cell screening. It enables high-resolution screening of antibody-secreting B cells with throughput and timeline previously unimaginable for antibody discovery.
Our scientists at Twist Biopharma Solutions are the first to adopt this state-of-the-art technology, meaning every obstacle or challenge has been tested and optimized to provide you with all the benefits this platform offers. Days after tissue collection, the Beacon provides a rich data set about each antibody screened to identify the rare and cross-reactive antibodies ideal for clinical development. Those antibodies are sequenced and rapidly expressed in-house to advance them to characterization and developability assays.
In vivo 抗体開発を数ヶ月ではなく数週間で行います
当社なら可能です。The Beacon-based B cell screening enables high-resolution screening for ideal, rare antibodies in previously impossible timelines.
Why is the Beacon Better?
The Beacon offers peak flexibility and resolution, evolved across 3 generations of single B cell screening technologies.
Our Expertise in Your Hands
Optimized Immunization and Screening Protocols
- Immunization strategies with various animals
- Choose our proprietary DiversimAb™ hyperimmune mouse
- Proprietary protocols are optimized for single B cell screening
- Assay components and reagent suite are optimized for specific applications
- Species for each workflow are fully validated to ensure scientific excellence
Unparalleled Speed from Hit to Lead
- Leverage the Beacon and our antibody discovery experts to rapidly discover high-quality antibodies with fewer wasted resources
- Screen antibodies for the desired profiles such as specificity, cross-reactivity, blocking functionality, on-cell binding
- Accelerate screening compared to the age-old method of developing and expressing hundreds or thousands of antibodies
Extensive Suite of On-Chip Screening Capabilities
- Standard assay formats are offered such as cell binding and ligand blocking in addition to multiplexed assays such as species cross-reactivity and high-homology specificity
- Twist has extensive experience validating complex assays on the Beacon platform
- Our in vivo antibody discovery experts also offer custom assay development for validation assays
An End-to-End Discovery Workflow
- The Beacon platform perfectly complements Twist’s in vivo antibody generation and characterization capabilities
- Our integrated approach ensures scientific integrity and rigor throughout your entire discovery and development program
- This allows us to anticipate and address any potential roadblocks to keep your projects on track and aligned with your goals
Our Expertise in Your Hands
Optimized Immunization and Screening Protocols
- Immunization strategies with various animals
- Choose our proprietary DiversimAb™ hyperimmune mouse
- Proprietary protocols are optimized for single B cell screening
- Assay components and reagent suite are optimized for specific applications
- Species for each workflow are fully validated to ensure scientific excellence
Unparalleled Speed from Hit to Lead
- Leverage the Beacon and our antibody discovery experts to rapidly discover high-quality antibodies with fewer wasted resources
- Screen antibodies for the desired profiles such as specificity, cross-reactivity, blocking functionality, on-cell binding
- Accelerate screening compared to the age-old method of developing and expressing hundreds or thousands of antibodies
Extensive Suite of On-Chip Screening Capabilities
- Standard assay formats are offered such as cell binding and ligand blocking in addition to multiplexed assays such as species cross-reactivity and high-homology specificity
- Twist has extensive experience validating complex assays on the Beacon platform
- Our in vivo antibody discovery experts also offer custom assay development for validation assays
An End-to-End Discovery Workflow
- The Beacon platform perfectly complements Twist’s in vivo antibody generation and characterization capabilities
- Our integrated approach ensures scientific integrity and rigor throughout your entire discovery and development program
- This allows us to anticipate and address any potential roadblocks to keep your projects on track and aligned with your goals
技術資料
技術資料
お問い合わせフォーム
抗体の専門家がお客様の開発ニーズについて詳しくお伺いいたします。難易度が高いと考えられる場合でもご遠慮なくお問い合わせください。
